Evidence map›Paper›PMID 37796615›Full record

ArticleJCI insight2023

Altered Sox9 and FGF signaling gene expression in Aga2 OI mice negatively affects linear growth.

Jennifer Zieba, Lisette Nevarez, Davis Wachtell, Jorge H Martin, Alexander Kot, Sereen Wong, Daniel H Cohn, Deborah Krakow

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jennifer ZiebaDepartment of Orthopaedic Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
Lisette NevarezDepartment of Molecular Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, California, USA.
Davis WachtellDepartment of Orthopaedic Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
Jorge H MartinDepartment of Orthopaedic Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
Alexander KotDepartment of Human Genetics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
Sereen WongDepartment of Psychology, University of California, Los Angeles, Los Angeles, California, USA.
Daniel H CohnDepartment of Orthopaedic Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
Deborah KrakowDepartment of Orthopaedic Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
University of California, Los Angeles · US

Funding

Project 3: Collagen post-translational modification and cross-linking in OIP01HD070394 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN · 2011 to 2020
$13.4M
Investigating pulmonary complications due to abnormal collagen/ER stress in Osteogenesis ImperfectaR01HL160554 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Jennifer Zieba · 2023 to 2026
$1.6M
NHLBI NIH HHS R01 HL160554NICHD NIH HHS P01 HD070394
6 · The paper itself

Abstract

Osteogenesis imperfecta (OI), or brittle bone disease, is a disorder characterized by bone fragility and increased fracture incidence. All forms of OI also feature short stature, implying an effect on endochondral ossification. Using the Aga2+/- mouse, which has a mutation in type I collagen, we show an affected growth plate primarily due to a shortened proliferative zone. We used single-cell RNA-Seq analysis of tibial and femoral growth plate tissues to understand transcriptional consequences on growth plate cell types. We show that perichondrial cells, which express abundant type I procollagen, and growth plate chondrocytes, which were found to express low amounts of type I procollagen, had ER stress and dysregulation of the same unfolded protein response pathway as previously demonstrated in osteoblasts. Aga2+/- proliferating chondrocytes showed increased FGF and MAPK signaling, findings consistent with accelerated differentiation. There was also increased Sox9 expression throughout the growth plate, which is expected to accelerate early chondrocyte differentiation but reduce late hypertrophic differentiation. These data reveal that mutant type I collagen expression in OI has an impact on the cartilage growth plate. These effects on endochondral ossification indicate that OI is a biologically complex phenotype going beyond its known impacts on bone to negatively affect linear growth.

Indexed as

Osteogenesis ImperfectaAnimalsCartilageCollagen Type IGene ExpressionMiceSOX9 Transcription FactorCollagen Type IProcollagen Type ISox9 protein, mouseSOX9 Transcription FactorBone BiologyCartilageCell stressDevelopmentGenetic diseases

Identifiers

PMID37796615
PMCPMC10721276
OpenAlexW4387378836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.